H35.133

Clinical Causes: Premature birth: infants born before completing 31 weeks of gestation are at higher risk. Low birth weight: babies weighing less than 1500 grams (3 pounds, 4 ounces) are more susceptible. Oxygen therapy: high levels of oxygen administered during neonatal care can contribute to abnormal retinal vessel growth. Genetic factors: family history and inherited predispositions may play a role. Other health complications: conditions such as anemia or respiratory issues can influence ROP development.

Key Symptoms: Typically, ROP does not cause noticeable symptoms in early stages. In some cases, abnormal eye movement or difficulty focusing may be observed. If the condition progresses, signs such as crossed eyes (strabismus) or poor vision may appear. Advanced stages can lead to retinal detachment, resulting in vision loss.

Diagnosis Path: Diagnosis involves a detailed eye examination by a pediatric ophthalmologist, usually performed during routine neonatal screenings. The key diagnostic method is indirect ophthalmoscopy, where the doctor examines the retina to assess the severity and stage of ROP. Retinal imaging and documentation may also be used to monitor disease progression over time.

Treatment Protocols: Treatment options for bilateral stage 2 ROP aim to prevent progression to more severe stages that can threaten vision. These include: - **Laser therapy**: using precise laser beams to ablate the peripheral retina and halt abnormal blood vessel growth. - **Cryotherapy**: an older method involving freezing abnormal vessels, now less commonly used. - **Monitoring**: in some cases, careful observation with regular follow-up examinations may be recommended if the ROP is not progressing. Early intervention can significantly reduce the risk of future vision impairment. The healthcare team will tailor the treatment plan based on the individual needs of the infant.